ArticleJournal of medicinal chemistry2022

Discovery of a First-in-Class Degrader for Nuclear Receptor Binding SET Domain Protein 2 (NSD2) and Ikaros/Aiolos.

Fanye Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.